Modernizing Safety Case Processing, Gedeon Richter Goes Live with LifeSphere® MultiVigilance
By moving from legacy systems to LifeSphere® MultiVigilance, the organization anticipates significant efficiency gains.
Raj Hattarki Appointed as Chief Operating Officer of ArisGlobal
By moving from legacy systems to LifeSphere® MultiVigilance, the organization anticipates significant efficiency gains.
Introducing Literature Intelligence Powered by LifeSphere NavaX
With the cloud-based solution, Boehringer Ingelheim creates a global single source of truth for case management, leveraging automation and reducing infrastructure costs.
Boehringer Ingelheim Expands LifeSphere MultiVigilance to Japan
With the cloud-based solution, Boehringer Ingelheim creates a global single source of truth for case management, leveraging automation and reducing infrastructure costs.
ArisGlobal and Sitero Expand Strategic Partnership to Enable Best-in-Class Capabilities Across Complete Drug Development Technology Platform
Strategic collaboration strengthens end-to-end connectivity & data flow across the drug development platform, ensuring seamless interoperability across Clinical, Safety, Regulatory, Medical Affairs, and Quality platforms.
ArisGlobal Achieves Record Customer Growth and Product Innovation in First Half 2024
Eight net new LifeSphere customers, 300% YoY increase in customer go-lives, and delivering innovation via LifeSphere NavaX
ArisGlobal Launches ‘Most Valued Customer Program’
ArisGlobal places all customers at the core of its operations.
Breakthrough Regulatory 2024 Speaker Lineup Announced
Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.
Montreal CRO MHICC Chooses LifeSphere® Safety to Process Adverse Event Cases as Part of Its Expansion into Post-Market Services
Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.
Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology
End-to-end functionality helps cut skyrocketing costs of compliance and removes workflow inefficiencies.
